Los Angeles, United States
Macro Trials, founded in 2021, positions itself as a transformative player in the Biopharma, Health Care, and Life Sciences industries. With the slogan, "Purpose-built for tomorrow’s clinical trial," the company offers a precision research clinical platform designed to enhance research speed and patient engagement, benefiting all stakeholders involved in the clinical trial ecosystem.
Headquartered in the United States, Macro Trials employs a digitally powered infrastructure with a "hub-and-spoke" model, enabling partnerships with pharmaceutical companies, CROs, providers, and health systems to execute trials for high-value therapeutics. Its platform provides specialized efficiency tools, research personnel, and a logistics network, while its clinical trial intelligence and proprietary RWEaaS product offer robust support in research and commercialization.
With a recent $6.00M Seed Round investment on 21 June 2023 from investors such as Healthy Ventures, Village Global, Inflect Health, Initiate Ventures, and MBX Capital, Macro Trials is poised for rapid growth within its target verticals.
